Partnerships

The sensor-laden device with a novel electronic dose counter is currently available for licensing and is expected to enter clinical studies later this year.

The company's solution is in use by over 500 hospitals and payers to efficiently manage, monitor and engage patient populations of all sizes and risk levels.

The system is designed to deliver more objective measurements, while also enabling patients to perform these tests from their homes.

The program will select companies specializing in the development of potential solutions for improved sleep, stress management, energy, aging and nutrition.

In March of this year, the two companies will launch a solution that connects mscripts' network of 6,000+ pharmacies with MPRS' savings and adherence programs.

ACT.md, Blue Cross Blue Shield of Massachusetts, and Brigham and Women's Hospital partner to improve coping for people with serious medical conditions.

The two companies aim to enable clinicians and patients to use the Diasend solution to review past CGM data along with insulin pump and activity tracker data.

With the addition of DreaMed's Advisor in Glooko's platform, insulin pump data can be assessed for patterns that yield personalized recommendations.

Partners will develop the solution that combines AHA's science-based metrics with cognitive analytics, delivered on Welltok's health optimization platform.

Nothing has been decided yet, and we may still be far from seeing the new company emerging; both parties have been active in the digital health space.